Source: Annual Congress 2005 - Progresses in granolomatous lung disease
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Bargagli, P. Anna, M. M. Antonietta, S. Grosso, P. Rottoli (Siena, Italy). Chitotriosidase as a possible marker of sarcoidosis activity. Eur Respir J 2005; 26: Suppl. 49, 3067

Member's Comments

No comment yet.

Related content which might interest you: The role of isoenzymes levels of ‘adenosine deaminase‘ in bronchoalveolar lavage fluid to determining activitiy of pulmonary tuberculosis Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI Year: 2005 Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) from patients with pulmonary sarcoidosis using SELDI-mass spectrometry Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 Involvement of lymphocytes in mycoplasma pneumoniae pneumonia is associated with elevation in KC, IL-6 and TNF-α levels in bronchoalveolar lavage fluid Source: Annual Congress 2007 - Immunological function in viral and nonviral pathogens Year: 2007 Identification of four proteins from a "sarcoidosis-associated protein profile": SELDI-TOF MS analysis of bronchoalveolar lavage fluid (BALF) Source: Annual Congress 2006 - Usefulness of broncoalveolar lavage (BAL) in interstitial lung diseases Year: 2006 Detection of extracellular proteasome in the human alveolar space Source: Annual Congress 2006 - Molecular airway biology Year: 2006 Perforin expression and lymphocytes adhesion molecules in patients with pulmonary sarcoidosis Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005 Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis Source: Eur Respir J 2003; 21: 407-413 Year: 2003 Bronchoalveolar lavage: how can we use it more effectively to define pathology? Source: Annual Congress 2006 - Molecular pathology: an approach to lung diseases Year: 2006 The analysis of tryptase in serum and bronchoalveolar lavage of sarcoidosis patients Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients Source: Eur Respir J 2003; 21: 52-57 Year: 2003 CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010 Cellular profiles of induced sputum in children with stable cystic fibrosis: comparison with BAL Source: Eur Respir J 2003; 22: 497-502 Year: 2003 Alveolar lymphocytes (AL) produce interleukin 27 (IL27), antigen presenting cell-secreted cytokine. Increased expression of IL27 in bronchoalveolar lavage (BAL) of pulmonary sarcoidosis (PS) patients Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Net inflammatory activity of bronchoalveolar lavage fluid (BALF) from patients following lung transplantation Source: Eur Respir J 2002; 20: Suppl. 38, 348s Year: 2002 Predictive value of BAL cell differentials in the diagnosis of interstitial lung diseases Source: Eur Respir J 2004; 24: 1000-1006 Year: 2004 Sputum rather than bronchoalveolar lavage (BAL) cells are associated with small airways function in COPD Source: Eur Respir J 2002; 20: Suppl. 38, 198s Year: 2002 Correlation between cellularity of bronchoalveolar lavage (BAL) and parameters of lung function (LF) in patients with sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 180s Year: 2003 Biochemical markers in bronchoalveolar lavage (BAL) Source: Eur Respir J 2001; 18: Suppl. 33, 385s Year: 2001 The impact of smoking on bronchoalveolar lavage fluid (BALf) amyloid A concentration in patients with sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013 Tryptase levels in bronchoalveolar lavage fluid (BALF) may predict the recurrence and chronicity of eosinophilic pneumonia Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019